Oncotelic Therapeutcs Inc (OTLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 249,025 | -4,780 | -8,206 | 4,677 | -10,517 |
| Depreciation Amortization | 198 | 3,322 | 6,385 | 6,099 | 1,516 |
| Income taxes - deferred | 111,550 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2 | 2 | 27 | 874 | 12 |
| Other Working Capital | 106 | 348 | -86 | 800 | 305 |
| Other Operating Activity | -362,265 | 367 | 560 | -13,902 | 4,250 |
| Operating Cash Flow | $-1,383 | $-740 | $-1,321 | $-1,453 | $-4,435 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 908 | 656 | 1,410 | N/A | 943 |
| Debt Issued | 478 | N/A | N/A | 966 | 2,123 |
| Common Stock Issued | N/A | N/A | -125 | 159 | 1,965 |
| Other Financing Activity | 0 | 0 | -35 | 0 | -502 |
| Financing Cash Flow | $1,386 | $656 | $1,250 | $1,125 | $4,529 |
| Beginning Cash Position | 106 | 190 | 262 | 589 | 494 |
| End Cash Position | 109 | 106 | 190 | 262 | 589 |
| Net Cash Flow | $3 | $-84 | $-71 | $-327 | $95 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,383 | -740 | -1,321 | -1,453 | -4,435 |
| Free Cash Flow | -1,383 | -740 | -1,321 | -1,453 | -4,435 |